MADISON, Wis.–(BUSINESS WIRE)–Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that it will present at the 26th Annual JPMorgan Healthcare Conference, which is being held Jan. 7-10, at the Westin St. Francis Hotel in San Francisco. Kevin T. Conroy, Third Wave’s president and chief executive, will make the company’s presentation on Thursday, Jan. 10, at 1:30 p.m. PST.
A live webcast of Mr. Conroy’s presentation will be available through the company’s website at www.twt.com and at http://www.metameetings.com/webcasts/jpmorgan/healthcare08. An archive of the webcast will be available following the conclusion of the conference.
About Third Wave Technologies
Third Wave develops and markets molecular diagnostic reagents for a variety of DNA and RNA analysis applications to meet the needs of our customers. The company offers a number of products based on its Invader® chemistry for clinical testing. Third Wave offers in vitro diagnostic kits, and analyte specific, general purpose, and research use only reagents for nucleic acid analysis. For more information about Third Wave and its products, please visit the company’s website at www.twt.com.
All statements in this news release that are not historical are forward-looking statements within the meaning of the Securities Exchange Act of 1934 as amended. Such forward-looking statements are subject to factors that could cause actual results to differ materially for Third Wave from those projected. Those factors include risks and uncertainties relating to the company’s ability to bring new products to market as anticipated, the current regulatory environment in which the company sells its products, the market acceptance of those products, dependence on partners and customers, successful performance under collaborative and commercial agreements, competition, the strength of the Third Wave intellectual property, the intellectual property of others and other risk factors identified in the documents Third Wave has filed, or will file, with the Securities and Exchange Commission. Copies of the Third Wave filings with the SEC may be obtained from the SEC Internet site at http://www.sec.gov. Third Wave expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in Third Wave’s expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. Third Wave Technologies, Invader and the Third Wave logo are trademarks of Third Wave Technologies, Inc.